Diabetes Medicine

Product Details:

Mounjaro 2.5mg is a once-weekly injection containing tirzepatide, a dual GIP and GLP-1 receptor agonist. Tirzepatide is the first medication of its kind that works by mimicking the effects of two natural gut hormones that help control blood sugar and regulate appetite. It is available only by prescription. The 2.5mg dose is typically the starting dose for Mounjaro and is not intended for long-term glycemic control or weight management. The dose is usually increased after four weeks based on individual patient response and tolerance. Important warnings

• Risk of thyroid cancer: Mounjaro carries a boxed warning about the risk of thyroid C-cell tumors. This medication should not be used by individuals with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine endocrine neoplasia syndrome type 2 (MEN 2).
• Not a long-term solution: For some, Mounjaro is not a lifelong requirement and may eventually be switched or adjusted based on your progress and doctor's advice.
• Pancreatitis: Mounjaro has been associated with reports of acute pancreatitis. If you experience severe abdominal pain, you should seek medical attention.
• Kidney problems: Severe gastrointestinal side effects like vomiting and diarrhea can lead to dehydration and, in some cases, acute kidney injury.
• Hypoglycemia: If Mounjaro is taken with other diabetes medications, particularly insulin or sulfonylureas, there is an increased risk of low blood sugar (hypoglycemia).
• Severe stomach issues: This medication can cause severe gastrointestinal problems and is not recommended for individuals with severe gastroparesis (stomach paralysis).
• Pregnancy and breastfeeding: Mounjaro is not recommended during pregnancy, as animal studies have shown potential risks to the unborn baby. Its use while breastfeeding is unknown.
• Drug interactions: It can delay gastric emptying, potentially affecting the absorption and effectiveness of oral medications, including oral contraceptives. 

UsesMounjaro is used for the following conditions:

Product Details:

Rybelsus 7mg Tablet is a medicine containing semaglutide used to improve blood sugar control in adults with type 2 diabetes.

Product Details:

JARDIANCE 25MG contains Empagliflozin which belongs to the group of medicines called Anti-diabetic drugs. It is used to treat type 2 diabetes in adults, that cannot be controlled by diet and exercise alone. It can also help to prevent heart disease in patients with type 2 diabetes mellitus.

Product Details:

The 3 mg Rybelsus (semaglutide) tablet is an oral prescription medication used to improve blood sugar (glucose) control in adults with type 2 diabetes. It is part of a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists. Rybelsus is used in combination with diet and exercise to help regulate blood sugar levels and, for patients with established cardiovascular disease, to reduce the risk of major heart-related events.

Product Details:

The 14 mg Rybelsus (semaglutide) tablet is an oral prescription medication used to improve blood sugar (glucose) control in adults with type 2 diabetes. It is part of a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists. Rybelsus is used in combination with diet and exercise to help regulate blood sugar levels and, for patients with established cardiovascular disease, to reduce the risk of major heart-related events.

Product Details:

Mounjaro 5 mg (tirzepatide) injection is a prescription medication primarily used, along with diet and exercise, to improve blood sugar control in adults with type 2 diabetes. It is administered as a once-weekly subcutaneous injection and can also aid in weight management due to its appetite-reducing effects. 

Product Details:

Linagliptin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. It is used by people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems.